The data is sourced from medical data records like prescriptions, lab reports, government datasets, surveys taken by the patient, data from device registries, clinical registries, and more.
Real-World Evidence (RWE) is defined by the US Food & Drug Administration (FDA) as “the clinical evidence regarding usage and potential benefits or risks of a medical product derived from analysis of real-world data.”
The actual usage of this evidence is to bridge the gap between the research results and the actual usage results of various medical products used by people.
Pre-trial research in Life Science studiesThe researchers benefit from RWE and can form an accurate pre-trial design, as they can include various pre-trail criteria.
They develop a product or medicine and RWE helps them to get a real-time preview of their products.
This leads to further research and development of the products.
This simplifies the approval granting procedure.
With the advent of vaccinations, we can see some hope at the end of the tunnel.Now the next series of questions that arise are about the distribution of vaccines, their drug toxicity, and if the vaccines can be modified for better results if required.The data-sets are processed & analyzed in a manner to provide valuable evidence for the betterment of healthcare services.The importance of RWD and RWE has been recognized by researchers, doctors, and pharmaceutical companies for a while.These data-sets have been a valuable source of information for decision-making.RWE opportunities but not without riskDue to the urgency to find a solution for the virus, researchers have extensively used the evidence to use existing drugs to treat the virus.But a few studies have shown reliable results.There could be long-term health consequences for people who have contracted the coronavirus.The effect of vaccination is yet to be seen.